AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0063
-0.0007 (-10.00%)
Mar 26, 2026, 12:50 PM EST
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $2.11 million as of March 26, 2026. Its market cap has increased by 111.70% in one year.
Market Cap
2.11M
Enterprise Value
n/a
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has increased from 1.98M to 2.11M, an increase of 6.74%. That is a compound annual growth rate of 0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 2.49M | -34.63% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 3.24M |
| Oncology Pharma | 3.09M |
| Burzynski Research Institute | 2.98M |
| CASI Pharmaceuticals | 2.93M |
| Clearside Biomedical | 2.67M |
| Vaccinex | 2.38M |
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.13M |